rarely is anything that simple with hormonesCorrect. It is not unheard of. Once it is stopped, the body continues the natural way as if it begun at around 12.
Puberty Blockers
https://www.transgendertrend.com/nhs-no-longer-puberty-blockers-reversible/
GONE is the claim that puberty blockers are considered to be fully reversible:
“The effects of treatment with GnRH analogues are considered to be fully reversible, so treatment can usually be stopped at any time after a discussion between you, your child and your MDT”.
NEW is the admission that long-term effects are unknown:
“Little is known about the long-term side effects of hormone or puberty blockers in children with gender dysphoria.
Although the Gender Identity Development Service (GIDS) advises this is a physically reversible treatment if stopped, it is not known what the psychological effects may be.
It’s also not known whether hormone blockers affect the development of the teenage brain or children’s bones. Side effects may also include hot flushes, fatigue and mood alterations.”
This paints a very different picture. The Tavistock GIDS is saying that the effects of blockers are physically reversible yet the NHS is now saying that this is not known.
Unknown effects on the developing adolescent brain should be reason enough to question the use of puberty blockers for this age-group; the fact that this has not been flagged before is testament to the existence of the seemingly different rules that govern transgender healthcare.
Would parents say yes to puberty blockers if they knew that trials on sheep suggest that blockers impair brain development in significant areas, which is not reversed if blockers are discontinued?
We know there is a window of development in puberty which, if missed, cannot be regained at a later stage.
We also know that nearly 100% of children on blockers progress to cross-sex hormones and we know nothing about the long-term neurological effects if a person never experiences the surge of sex hormones their body needs and expects in adolescence according to whether they are male or female.
Three new conditions have been added to the list of risks of cross-sex hormones:
Dyslipidaemia (abnormal levels of fat in the blood)
Elevated liver enzymes
Polycythaemia (high concentration of red blood cells)